Bosh sahifaHLUN-B • CPH
add
H Lundbeck A/S Class B
Yopilish kursi
43,22 kr
Kunlik diapazon
42,52 kr - 44,40 kr
Yillik diapazon
27,20 kr - 47,78 kr
Bozor kapitalizatsiyasi
41,40 mlrd DKK
Oʻrtacha hajm
730,14 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (DKK) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 6,09 mlrd | 9,96% |
Joriy xarajat | 4,36 mlrd | 12,55% |
Sof foyda | -27,00 mln | -104,58% |
Sof foyda marjasi | -0,44 | -104,13% |
Har bir ulushga tushum | 0,94 | -30,88% |
EBITDA | 956,00 mln | -2,65% |
Amaldagi soliq stavkasi | 107,50% | — |
Balans
Jami aktivlari
Jami passivlari
| (DKK) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,43 mlrd | -26,39% |
Jami aktivlari | 52,05 mlrd | -9,72% |
Jami passivlari | 27,15 mlrd | -16,84% |
Umumiy kapital | 24,90 mlrd | — |
Tarqatilgan aksiyalar | 991,23 mln | — |
Narxi/balansdagi bahosi | 1,72 | — |
Aktivlardan daromad | 2,33% | — |
Kapitaldan daromad | 3,31% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (DKK) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -27,00 mln | -104,58% |
Operatsiyalardan naqd pul | 921,00 mln | 179,81% |
Sarmoyadan naqd pul | -202,00 mln | 98,65% |
Moliyadan naqd pul | -765,00 mln | -106,15% |
Naqd pulning sof oʻzgarishi | -46,00 mln | 98,74% |
Boʻsh pul | 944,38 mln | -46,59% |
Haqida
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
Tashkil etilgan
14-avg, 1915
Sayt
Xodimlar soni
5 039
